CarMeN Laboratory INRAE UMR1397-INSERM U1060
CarMeN Laboratory is a French public biomedical research unit (INSERM U1060 / INRAE U1397 / Université Lyon 1) dedicated to cardiovascular, metabolic, diabetes, and nutrition research, operating three teams and six technical platforms across two Lyon-area hospital sites.
- Company typePrivate
- Founded2011
- HeadquartersPierre-Bénite, France
- Headcount51–100
- GTM typeB2B
- OfferingServices
What CarMeN Laboratory INRAE UMR1397-INSERM U1060 does
CarMeN Laboratory (INSERM U1060 / INRAE U1397 / Université Claude Bernard Lyon 1) is a public, non-profit biomedical research unit (Unité Mixte de Recherche) created in Lyon in January 2011 and jointly supervised by INSERM, INRAE, Université Lyon 1, and Hospices Civils de Lyon. It is dedicated to research on cardiovascular disease, metabolism, diabetes, and nutrition, organized into three research teams (DO-IT, MERISM, IRIS) plus a support team, operating across two sites: Lyon Sud Hospital (Pierre-Bénite) and Groupement Hospitalier Est (Bron).
The laboratory maintains six specialized technical platforms — Cytometry, Genomics, Histology, Ixplora (in vivo exploration), Microscopy, and the ISO 9001:2015-certified CarMeN Biobank — and an affiliated clinical research platform, CRNH Rhône-Alpes, which conducts human nutrition studies and recruits voluntary participants. Core technology comprises advanced confocal and live-cell imaging systems (Nikon A1R+, Leica, IonOptix), cryopreservation infrastructure (11 LN₂ tanks, 15 -80°C freezers), and a biological sample repository spanning human and animal specimens collected since founding.
CarMeN does not commercialize products. Funding flows from French public research institutions (INSERM, INRAE, Université Lyon 1, Hospices Civils de Lyon) and competitive national/European grants (ANR, ERA4Health). The CRNH platform generates in-kind research output (clinical nutrition studies with voluntary participants indemnified €150–€600 per study) rather than commercial revenue. Outputs are disseminated through peer-reviewed publications (Lancet, Gut, Kidney International, Nature Cell Biology, J. Extracell. Vesicles), conference presentations, and educational programs including the MuSkLE Summer School.
CarMeN Laboratory INRAE UMR1397-INSERM U1060 firmographics
Firmographics- Name
- CarMeN Laboratory INRAE UMR1397-INSERM U1060
- Legal name
- Laboratoire CarMeN - Cardiovasculaire, Métabolisme, Diabète et Nutrition
- Website
- https://carmen.univ-lyon1.fr
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- CarMeN Laboratory is a French public biomedical research unit (INSERM U1060 / INRAE U1397 / Université Lyon 1) dedicated to cardiovascular, metabolic, diabetes, and nutrition research, operating three teams and six technical platforms across two Lyon-area hospital sites.
- Ownership category
- akta.pro rank
CarMeN Laboratory INRAE UMR1397-INSERM U1060 industry classification
Industry- Product category
- Biomedical Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where CarMeN Laboratory INRAE UMR1397-INSERM U1060 is headquartered
LocationHeadquarters
- HQ city
- Pierre-Bénite
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
CarMeN Laboratory INRAE UMR1397-INSERM U1060 business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Public Research Funding: Funded through institutional affiliations with INSERM, INRAE, and Université Lyon 1. Receives grants from national research agencies and participates in European funding programs (ERA4Health). Revenue comes from public research financing rather than commercial operations.
- Clinical Research Services: Conducts clinical nutrition studies through the Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) platform. Studies are authorized by CPP ethics committees and ANSM, and may receive public research funding.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time | Volunteer compensation for clinical nutrition studies |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
CarMeN Laboratory INRAE UMR1397-INSERM U1060 product offering
Product offeringCore offering
CarMeN is a French biomedical research laboratory conducting fundamental and translational research on cardiovascular diseases, metabolism, diabetes, and nutrition. It operates three research teams (DO-IT, MERISM, IRIS) and provides access to six specialized technical platforms (cytometry, genomics, histology, Ixplora, microscopy, and biobank). The affiliated CRNH Rhône-Alpes clinical research platform conducts human nutrition studies and recruits volunteers, while the laboratory maintains ISO 9001:2015 certified quality management.
Product overview
CarMeN Laboratory is a biomedical research institution (INSERM U1060/INRAE U1397/Université Lyon1) dedicated to research in cardiovascular disease, metabolism, diabetes, and nutrition. The laboratory operates three research teams (DO-IT focusing on food and intestinal therapeutics for obesity, MERISM focusing on mitochondria-ER interactions in metabolic diseases, and IRIS focusing on ischemia-reperfusion syndromes) and provides access to six technical platforms (Cytometry, Genomics, Histology, Ixplora, Microscopy, and Biobank). The affiliated CRNH Rhône-Alpes Clinical Research Platform conducts human nutrition studies and recruits volunteers for health nutrition research.
Differentiator
Problem solved
Functional benefit
Products and services
- Cytometry Platform
Quantifiable outcome
- 10th consecutive ISO 9001:2015 certification achieved in June 2023, demonstrating sustained quality management over 10+ years
- +3 more outcomes
Companies that use CarMeN Laboratory INRAE UMR1397-INSERM U1060
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
CarMeN Laboratory INRAE UMR1397-INSERM U1060 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CarMeN Laboratory INRAE UMR1397-INSERM U1060 partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- IHU EverestminorInstitute hosting the symposium on Hepatic Organoids & Ex Vivo 3D Models organized by Jennifer Rieusset at Lyon Sud. Collaborative platform for liver research using organoid and 3D model technologies.
- Federal University of Paraíba - BrazilminorFranco-Brazilian research collaboration through CAPES-COFECUB project coordinated by Prof. Marciane Magnani, partnering with Prof. Hubert Vidal on probiotic and prebiotic research.
- Federal University of Pernambuco (UFPE) - BrazilminorFranco-Brazilian cooperation through CAPES-COFECUB project on translational evaluation of probiotics and prebiotics. Hosting of Prof. Carol Gois Leandro for collaborative seminar on VITORIA project (obesity reduction in adolescents).
- Université Laval - CanadaminorHosted Prof. Benoît Arsenault for seminar on body weight and health research. Researcher at Institut de cardiologie et de pneumologie du Québec focusing on cardiometabolic risk markers and lifestyle modification interventions.
- INSERM U1060coreInstitut national de la santé et de la recherche médicale - primary institutional affiliation providing research framework, funding, and personnel oversight. Laboratory created at Lyon in January 2011 under this partnership and renewed in 2016 and January 2021.
- INRAE U1397coreInstitut national de recherche pour l'agriculture, l'alimentation et l'environnement - institutional partner co-managing the laboratory. Part of the joint INSERM U1060/INRAE U1397 structure.
- Université Lyon 1 (Claude Bernard)coreUniversité Claude Bernard Lyon 1 - academic partner providing university framework, student training, and research supervision for doctoral programs.
- Hospices Civils de LyoncorePublic hospital system hosting the laboratory at Lyon Sud Hospital and providing clinical research infrastructure and patient access for cardio-metabolic studies.
- Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA)coreClinical nutrition research platform integrated into the CarMeN laboratory structure, located at Lyon Sud Hospital. Conducts human nutrition studies with authorized clinical research protocols.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
CarMeN Laboratory INRAE UMR1397-INSERM U1060 competitors and assessment
Company assessmentBroad incumbents
- Pasteur Institute: Major French non-profit biomedical research institution. Comparable to CarMeN's non-profit public research model, multi-platform structure, and translational publication record, though broader in scope.
- Karolinska Institutet: Leading European medical university conducting biomedical and clinical research including metabolic disease. Comparable to CarMeN in academic research mission, publication output, and clinical-trial execution capability, though operating at much larger scale.
- CNRS (Centre National de la Recherche Scientifique): France's largest public research organization. Comparable as a parent-equivalent public research framework operating under similar French institutional funding mechanisms and shared laboratory hosting arrangements.
- Institut Necker-Enfants Malades (INEM, INSERM U1151): French INSERM biomedical research unit. Comparable as a French academic biomedical research organization operating under similar institutional frameworks and grant structures, though its focus is broader and less cardio-metabolic-centric.
Direct peers
- MRC Metabolic Diseases Unit (University of Cambridge): UK-based academic unit focused on metabolic disease mechanisms, sharing CarMeN's cardio-metabolic research mandate and bench-to-clinic translation pathway.
- Max Planck Institute for Metabolism Research: German research institute dedicated to metabolism, obesity, and diabetes research. Highly comparable to CarMeN given the overlapping cardio-metabolic disease focus and basic-to-translational research model, though operating at larger scale.
- Institut de Cardiologie et de Pneumologie de Québec (IUCPQ): Canadian cardiovascular research center that hosted CarMeN's collaboration with Prof. Benoît Arsenault. Comparable given overlapping cardio-metabolic risk-marker research and lifestyle intervention clinical studies.
- INRAE Centre for Human Nutrition Research: Parent-affiliated INRAE unit focused on nutrition research. Closely comparable as a French nutrition research organization sharing CarMeN's INRAE U1397 institutional framework and human nutrition methodology.
- IHU Everest (Institut Hospitalo-Universitaire): French institute focused on liver and metabolic disease organoid/3D-model research. Direct peer given CarMeN's collaboration with IHU Everest on hepatic organoid research and overlapping MASLD/translational focus.
Emerging players
- Nestlé Institute of Health Sciences: Industry-led nutrition and metabolic health research arm operating with similar cardio-metabolic and nutrition themes. Comparable to CarMeN's translational nutrition research scope but backed by private-sector funding rather than public grants.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CarMeN Laboratory INRAE UMR1397-INSERM U1060 social profiles
Digital presenceCarMeN Laboratory INRAE UMR1397-INSERM U1060 compliance and trust
Trust signalCompliance1 record
CarMeN Laboratory INRAE UMR1397-INSERM U1060 financial estimates
Financial estimateRevenue estimate
Valuation estimate
CarMeN Laboratory INRAE UMR1397-INSERM U1060 leadership team
Management profileNumber of profiles
Profiles7 records
CarMeN Laboratory INRAE UMR1397-INSERM U1060 subsidiaries and ownership
Company hierarchySubsidiaries1 record
CarMeN Laboratory INRAE UMR1397-INSERM U1060 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CarMeN Laboratory INRAE UMR1397-INSERM U1060 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CarMeN Laboratory INRAE UMR1397-INSERM U1060
What does CarMeN Laboratory INRAE UMR1397-INSERM U1060 do?
CarMeN is a French biomedical research laboratory conducting fundamental and translational research on cardiovascular diseases, metabolism, diabetes, and nutrition. It operates three research teams (DO-IT, MERISM, IRIS) and provides access to six specialized technical platforms (cytometry, genomics, histology, Ixplora, microscopy, and biobank). The affiliated CRNH Rhône-Alpes clinical research platform conducts human nutrition studies and recruits volunteers, while the laboratory maintains ISO 9001:2015 certified quality management.
Is CarMeN Laboratory INRAE UMR1397-INSERM U1060 a public or private company?
CarMeN Laboratory INRAE UMR1397-INSERM U1060 is a private company. It is classified as state government owned and is currently operating.
When was CarMeN Laboratory INRAE UMR1397-INSERM U1060 founded?
CarMeN Laboratory INRAE UMR1397-INSERM U1060 was founded in 2011. It employs 51 to 100 people.
Where is CarMeN Laboratory INRAE UMR1397-INSERM U1060 based?
CarMeN Laboratory INRAE UMR1397-INSERM U1060 is headquartered in Pierre-Bénite, France, in the Europe region.
How does CarMeN Laboratory INRAE UMR1397-INSERM U1060 make money?
Two revenue lines are on record. Public Research Funding is the primary driver. The others are clinical Research Services.
Who are CarMeN Laboratory INRAE UMR1397-INSERM U1060's main competitors?
Broad incumbents on record are Pasteur Institute, Karolinska Institutet, CNRS (Centre National de la Recherche Scientifique) and Institut Necker-Enfants Malades (INEM, INSERM U1151). Direct peers are MRC Metabolic Diseases Unit (University of Cambridge), Max Planck Institute for Metabolism Research, Institut de Cardiologie et de Pneumologie de Québec (IUCPQ), INRAE Centre for Human Nutrition Research and IHU Everest (Institut Hospitalo-Universitaire). Nestlé Institute of Health Sciences is listed as an emerging player.
Does CarMeN Laboratory INRAE UMR1397-INSERM U1060 have an API?
No public API is recorded for CarMeN Laboratory INRAE UMR1397-INSERM U1060.
What industry is CarMeN Laboratory INRAE UMR1397-INSERM U1060 in?
CarMeN Laboratory INRAE UMR1397-INSERM U1060's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 541714 and its SIC code is 8731.